11 – 20 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma : An EAACI position paper
- Contribution to journal › Article
-
Mark
EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care
- Contribution to journal › Article
-
Mark
Biologics in severe asthma : A pragmatic approach for choosing the right treatment for the right patient
- Contribution to journal › Article
-
Mark
Integrating innovations in asthma research into clinical practice
- Contribution to journal › Debate/Note/Editorial
-
Mark
A EUFOREA comment on a lost comorbidity of asthma
- Contribution to journal › Letter
-
Mark
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
- Contribution to journal › Scientific review
-
Mark
Eosinophils—from cradle to grave
- Contribution to journal › Article
-
Mark
Pre-asthma : a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1—allergic asthma
- Contribution to journal › Scientific review
-
Mark
Evaluating treatment response to mepolizumab in patients with severe CRSwNP*
- Contribution to journal › Article
-
Mark
Efficacy of FP-025 : A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma
- Contribution to journal › Letter